.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The HIPARCO randomized trial examined the effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and resistant hypertension. Adults receiving multiple antihypertensive drugs were randomized to CPAP or no CPAP while continuing their usual medical treatment. After follow-up, CPAP produced a modest but clinically relevant improvement in 24-hour blood pressure measures and increased the proportion of patients who achieved a better nocturnal blood pressure pattern. The study reinforces an important clinical screening message: obstructive sleep apnea should be considered in patients whose hypertension remains difficult to control, even when classic symptoms such as loud snoring are not the presenting complaint. For respiratory physicians, the value of the paper is also multidisciplinary. OSA treatment is not only about sleepiness and sleep quality; it can contribute to cardiovascular risk management. The findings support the conference session emphasis on screening triggers beyond snoring, including resistant hypertension and metabolic disease, and they show why sleep assessment can be clinically meaningful across internal medicine and pulmonary practice.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The HIPARCO randomized trial examined the effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and resistant hypertension. Adults receiving multiple antihypertensive drugs were randomized to CPAP or no CPAP while continuing their usual medical treatment. After follow-up, CPAP produced a modest but clinically relevant improvement in 24-hour blood pressure measures and increased the proportion of patients who achieved a better nocturnal blood pressure pattern. The study reinforces an important clinical screening message: obstructive sleep apnea should be considered in patients whose hypertension remains difficult to control, even when classic symptoms such as loud snoring are not the presenting complaint. For respiratory physicians, the value of the paper is also multidisciplinary. OSA treatment is not only about sleepiness and sleep quality; it can contribute to cardiovascular risk management. The findings support the conference session emphasis on screening triggers beyond snoring, including resistant hypertension and metabolic disease, and they show why sleep assessment can be clinically meaningful across internal medicine and pulmonary practice.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
